Clinical trials
Inflammatory Bowel Diseases trials in Argentina
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
16 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 1 |
| 2010 | 1 |
| 2017 | 1 |
| 2018 | 3 |
| 2020 | 1 |
| 2021 | 1 |
| 2022 | 1 |
| 2023 | 2 |
| 2024 | 3 |
| 2025 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 5 |
| Recruiting | 4 |
| Active, not recruiting | 3 |
| Unknown status | 2 |
| Enrolling by invitation | 1 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Eli Lilly and Company | 3 |
| Spyre Therapeutics, Inc. | 2 |
| Takeda | 2 |
| Bai, Julio M.D. | 1 |
| Centro de Educación Medica e Investigaciones Clínicas Norberto Quirno | 1 |
| Grupo Argentino de Enfermedad de Crohn y Colitis Ulcerosa | 1 |
| Hospital Italiano de Buenos Aires | 1 |
| Hospital Nacional Profesor Alejandro Posadas | 1 |
| Merck Sharp & Dohme LLC | 1 |
| Pfizer | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Inflammatory Bowel Diseases | 16 |
| Colitis, Ulcerative | 11 |
| Colitis | 3 |
| Crohn Disease | 3 |
| Adrenal Hyperplasia, Congenital | 1 |
| Amyloidosis | 1 |
| Angioedemas, Hereditary | 1 |
| Cardiomyopathy, Hypertrophic | 1 |
| Celiac Disease | 1 |
| Colonic Diseases | 1 |
Trials
Showing 1 to 16 of 16. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.